British Association of Dermatologists Centenary Year: Standing on the Shoulders of Giants

January 2020 in “ British Journal of Dermatology ”

John R. Ingram, David J. Gawkrodger

androgenetic alopecia Dermatology Life Quality Index DLQI etanercept psoriasis nonmelanoma skin cancer androgenic alopecia Enbrel

TLDR The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

In 2020, the British Association of Dermatologists (BAD) celebrated its centenary by reflecting on landmark publications in its journals, the BJD and Clinical and Experimental Dermatology (CED). Notable papers included Ludwig's classification of androgenetic alopecia in women, based on 468 cases, and the Dermatology Life Quality Index (DLQI), which has been cited over 2000 times and is a key tool in assessing the impact of skin conditions on quality of life. The paper also highlighted a randomized controlled trial of etanercept for psoriasis involving 583 participants, which showed significant improvement in symptoms. The most-cited BJD paper since 2010 was a systematic review of worldwide incidence of nonmelanoma skin cancer, with the highest rates found in Australia.

View this study on academic.oup.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex

666 citations, September 1977 in “British Journal of Dermatology”

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Similar Research

5 / 1000+ results

research Neuroimaging of Sleep and Depression

June 2016 in “CRC Press eBooks”

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Efficacy and Safety of Topical Rosuvastatin and Melatonin vs. Placebo in Patients with Mild to Moderate Plaque Psoriasis: A Preliminary Randomized Double-Blinded Clinical Trial

research Efficacy and Safety of Topical Rosuvastatin and Melatonin vs. Placebo in Patients with Mild to Moderate Plaque Psoriasis: A Preliminary Randomized Double-Blinded Clinical Trial

1 citations, April 2024 in “Skin research and technology”

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

research Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis

291 citations, January 2014 in “The Scientific World Journal”

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

research Randomized Split-Side Study Comparing Efficacy of Botulinum Toxin Type A Versus 0.9% Sodium Chloride in Scalp Psoriasis

January 2018

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

research Main Plenary Sessions: Summaries of Papers

June 2008 in “British Journal of Dermatology”

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

British Association of Dermatologists Centenary Year: Standing on the Shoulders of Giants

Research cited in this study

research Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex

Related Community Posts Join

community Binding affinity of pyrilutamide!

community Dutasteride SAVES your hair follicles: MAJOR BS on people who say it destroyed their hair permanently.

community Transient and Permanent Effects of Finasteride Use

community Some more realistic 15 months fin+min results. No loss, but also basically no growth. HT unfortunately seems like the only option left at this point :/

community Quit vaping/smoking = 80% less loss